In terms of weight loss, there was no significant difference between weight loss with EX (-3.6 kg) and with EX-LAR (-3.7 kg) (115)
Saffron extract Increasingly trendy in appetite-control supplements
Commercially available GLP-1 patches lack clinical evidence for safety and efficacy and might lead to adverse reactions
Early research suggests patches might lower some gastrointestinal side effects by releasing medication more steadily, but this has not been confirmed in human studies
Additionally, Waltzek noted the immense potential that the food and beverage industry can provide to GLP-1 users experiencing negative side effects or curious consumers worried about them
With upcoming IRA price negotiations, potential PBM rebate structure reforms, and increasing regulatory scrutiny of DTC and compounded GLP-1 providers, employers must stay current with their formulary and coverage decisions